Literature DB >> 8893378

Intracellular persistence of Borrelia burgdorferi in human synovial cells.

H J Girschick1, H I Huppertz, H Rüssmann, V Krenn, H Karch.   

Abstract

To investigate if Borrelia burgdorferi can persist in resident joint cells, an infection model using cell cultures of human synovial cells was established and compared to the interaction of Borrelia burgdorferi and human macrophages. Borrelia burgdorferi were found attached to the cell surface or folded into the cell membrane of synovial cells analysed by transmission electron and confocal laser scanning microscopy. In contrast to macrophages, morphologically intact Borrelia burgdorferi were found in the cytosol of synovial cells without engulfment by cell membrane folds or phagosomes. Borrelia burgdorferi were isolated from parallel cultures. Treatment with ceftriaxone eradicated extracellular Borrelia burgdorferi, but spirochetes were reisolated after lysis of the synovial cells. Borrelia burgdorferi persisted inside synovial cells for at least 8 weeks. These data suggested that Borrelia burgdorferi might be able to persist within resident joint cells in vivo.

Entities:  

Mesh:

Year:  1996        PMID: 8893378     DOI: 10.1007/bf01409985

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  29 in total

1.  Penetration of endothelial cell monolayers by Borrelia burgdorferi.

Authors:  L E Comstock; D D Thomas
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

2.  Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis.

Authors:  J Schmidli; T Hunziker; P Moesli; U B Schaad
Journal:  J Infect Dis       Date:  1988-10       Impact factor: 5.226

3.  T cell proliferation induced by Borrelia burgdorferi in patients with Lyme borreliosis. Autologous serum required for optimum stimulation.

Authors:  A Krause; V Brade; C Schoerner; W Solbach; J R Kalden; G R Burmester
Journal:  Arthritis Rheum       Date:  1991-04

4.  Type I and type IV collagen promote adherence and spreading of human type II pneumocytes in vitro.

Authors:  T Papadopoulos; L Ionescu; J Dämmrich; H Toomes; H K Müller-Hermelink
Journal:  Lab Invest       Date:  1990-05       Impact factor: 5.662

5.  Diagnostic value of synovial fluid analysis in children with reactive arthritis.

Authors:  H I Huppertz; H Karch; J Heesemann
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

6.  An OspB mutant of Borrelia burgdorferi has reduced invasiveness in vitro and reduced infectivity in vivo.

Authors:  A Sadziene; A G Barbour; P A Rosa; D D Thomas
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

Review 7.  Current recommendations for the treatment of Lyme disease.

Authors:  L H Sigal
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

8.  Intracellular localization of Borrelia burgdorferi within human endothelial cells.

Authors:  Y Ma; A Sturrock; J J Weis
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

9.  Infectivity of Borrelia burgdorferi correlates with resistance to elimination by phagocytic cells.

Authors:  K Georgilis; A C Steere; M S Klempner
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

10.  Persistence of Borrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme borreliosis.

Authors:  T Häupl; G Hahn; M Rittig; A Krause; C Schoerner; U Schönherr; J R Kalden; G R Burmester
Journal:  Arthritis Rheum       Date:  1993-11
View more
  29 in total

Review 1.  The emergence of Lyme disease.

Authors:  Allen C Steere; Jenifer Coburn; Lisa Glickstein
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

2.  Expression of ICAM-1, ICAM-2, NCAM-1 and VCAM-1 by human synovial cells exposed to Borrelia burgdorferi in vitro.

Authors:  Sunit K Singh; Verena Baar; Henner Morbach; Hermann J Girschick
Journal:  Rheumatol Int       Date:  2005-11-24       Impact factor: 2.631

3.  Modulation of cytokine release in ex vivo-stimulated blood from borreliosis patients.

Authors:  I Diterich; L Härter; D Hassler; A Wendel; T Hartung
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

4.  Therapeutic passive vaccination against chronic Lyme disease in mice.

Authors:  W Zhong; T Stehle; C Museteanu; A Siebers; L Gern; M Kramer; R Wallich; M M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

5.  Resolution of Lyme arthritis, acute or prolonged: a new look.

Authors:  S E Malawista
Journal:  Inflammation       Date:  2000-12       Impact factor: 4.092

6.  Global transcriptome analysis of Borrelia burgdorferi during association with human neuroglial cells.

Authors:  Jill A Livengood; Virginia L Schmit; Robert D Gilmore
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

7.  Borrelia burgdorferi-induced tolerance as a model of persistence via immunosuppression.

Authors:  Isabel Diterich; Carolin Rauter; Carsten J Kirschning; Thomas Hartung
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

8.  IL-10 Deficiency Reveals a Role for TLR2-Dependent Bystander Activation of T Cells in Lyme Arthritis.

Authors:  Sarah K Whiteside; Jeremy P Snook; Ying Ma; F Lynn Sonderegger; Colleen Fisher; Charisse Petersen; James F Zachary; June L Round; Matthew A Williams; Janis J Weis
Journal:  J Immunol       Date:  2018-01-12       Impact factor: 5.422

Review 9.  [Lyme arthritis in children and adolescents].

Authors:  F Dressler; H-I Huppertz
Journal:  Z Rheumatol       Date:  2008-03       Impact factor: 1.372

Review 10.  Lyme Disease Frontiers: Reconciling Borrelia Biology and Clinical Conundrums.

Authors:  Vladimir V Bamm; Jordan T Ko; Iain L Mainprize; Victoria P Sanderson; Melanie K B Wills
Journal:  Pathogens       Date:  2019-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.